Fulgent Genetics, Inc.
FLGT
$18.92
-$0.64-3.27%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 73.46M | 76.21M | 71.74M | 71.03M | 64.49M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 73.46M | 76.21M | 71.74M | 71.03M | 64.49M |
| Cost of Revenue | 45.12M | 44.37M | 44.97M | 44.54M | 42.38M |
| Gross Profit | 28.35M | 31.85M | 26.77M | 26.49M | 22.10M |
| SG&A Expenses | 33.76M | 33.88M | 30.07M | 29.92M | 30.48M |
| Depreciation & Amortization | 1.99M | 1.99M | 1.99M | 1.99M | 1.99M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 93.26M | 92.35M | 88.82M | 89.93M | 86.28M |
| Operating Income | -19.80M | -16.14M | -17.08M | -18.91M | -21.80M |
| Income Before Tax | -11.72M | -8.05M | -18.53M | -11.21M | -14.17M |
| Income Tax Expenses | 176.00K | -1.86M | -3.84M | -2.12M | -327.00K |
| Earnings from Continuing Operations | -11.90M | -6.19M | -14.69M | -9.09M | -13.85M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 369.00K | 302.00K | 46.00K | 380.00K | 384.00K |
| Net Income | -11.53M | -5.89M | -14.65M | -8.71M | -13.46M |
| EBIT | -19.80M | -16.14M | -17.08M | -18.91M | -21.80M |
| EBITDA | -13.88M | -9.94M | -11.16M | -12.75M | -15.14M |
| EPS Basic | -0.37 | -0.19 | -0.48 | -0.29 | -0.45 |
| Normalized Basic EPS | -0.23 | -0.15 | -0.17 | -0.22 | -0.28 |
| EPS Diluted | -0.37 | -0.19 | -0.48 | -0.29 | -0.45 |
| Normalized Diluted EPS | -0.23 | -0.15 | -0.17 | -0.22 | -0.28 |
| Average Basic Shares Outstanding | 30.83M | 30.65M | 30.42M | 30.10M | 29.77M |
| Average Diluted Shares Outstanding | 30.83M | 30.65M | 30.42M | 30.10M | 29.77M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |